甲状腺切除术治疗症状持续存在的甲状腺功能正常桥本甲状腺炎患者:成本效益分析
本研究采用Markov模型,比较全甲状腺切除术与单纯药物治疗对甲状腺功能正常但症状持续的桥本甲状腺炎患者的终身成本效益。结果显示,全甲状腺切除术费用低1490美元且多获得1.4个质量调整生命年,在89%的概率敏感分析中为最优策略。结论认为全甲状腺切除术更具成本效益。
要点
- 全甲状腺切除术较单纯药物治疗费用低1490美元,多获得1.4个QALY。
- 概率敏感分析中全甲状腺切除术在89%的情况下为最优策略。
- 若全甲状腺切除术费用增加25%或永久并发症概率增加12倍,药物治疗将具成本效益。
核心结论
- 对于甲状腺功能正常但症状持续的桥本甲状腺炎患者,全甲状腺切除术比单纯药物治疗更具成本效益。
研究设计与样本
- 采用Markov模型,比较全甲状腺切除术与单纯药物治疗的终身成本效益,参数来自文献和Medicare成本数据,支付意愿阈值为每QALY 100000美元。
主要发现
- 单纯药物治疗平均费用12845美元,产生16.9个QALY,被全甲状腺切除术支配。
- 全甲状腺切除术费用低1490美元,多产生1.4个QALY。
- 概率敏感分析证实全甲状腺切除术在89%的情况下为最优策略。
关键数值与推荐
- 全甲状腺切除术费用增加25%时,单纯药物治疗将变得具有成本效益。
- 全甲状腺切除术后永久并发症概率增加12倍时,单纯药物治疗将变得具有成本效益。
- 甲状腺切除术后生活质量无改善时,单纯药物治疗将变得具有成本效益。
临床怎么用
- 对于甲状腺功能正常但症状持续的桥本甲状腺炎患者,可考虑全甲状腺切除术作为更具成本效益的选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite thyroid hormone replacement, some euthyroid patients with Hashimoto thyroiditis will continue to experience persistent symptoms that reduce their quality of life. Recent studies indicate that total thyroidectomy is superior to medical therapy alone in improving these symptoms. However, there is a high complication rate after total thyroidectomy in patients with Hashimoto thyroiditis. This study evaluates the cost-effectiveness of total thyroidectomy for euthyroid patients who have Hashimoto thyroiditis with persistent symptoms. METHODS: We utilized a Markov model to compare total thyroidectomy and medical therapy alone over the lifetime of the cohort. Costs, probabilities, and utility parameters were derived from literature and Medicare cost data. A willingness-to-pay threshold of $100,000/quality-adjusted life years was used. We performed sensitivity analyses to ascertain model uncertainty. RESULTS: On average, medical therapy alone costs $12,845, produced 16.9 quality-adjusted life years, and was dominated. Total thyroidectomy costs $1,490 less and produced 1.4 more quality-adjusted life years. Probabilistic sensitivity analysis confirmed total thyroidectomy as the optimal strategy in 89% of cases. Medical therapy alone will become cost-effective if the cost of uncomplicated thyroidectomy increases by 25%, if the probability of permanent complication after total thyroidectomy increases 12-fold, or if there is no gain in quality of life after thyroidectomy. CONCLUSION: Total thyroidectomy is more cost-effective than medical therapy alone for the management of euthyroid patients who have Hashimoto thyroiditis with persistent symptoms.
引用
- Memeh K, Ruhle B, Vaghaiwalla T, et al. Thyroidectomy for euthyroid patients with Hashimoto thyroiditis and persisting symptoms: A cost-effectiveness analysis. Surgery. 2020. PMID: 32460999. doi:10.1016/j.surg.2020.03.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。